CAFC News Brief

STR is appealing a decision from the District Court for the District of Delaware, which dismissed their patent infringement lawsuit. The district court ruled that the asserted claims of STR's '988 patent, which concerns a system and method for determining the taxability status of an aircraft, were invalid because they were directed to an abstract idea without an inventive concept. The Court of App...

Topics covered include prosecution history disclaimer and its interaction with litigation stipulations in a Hatch-Waxman case (Azurity v. Alkem), the analysis of patent eligibility under 35 U.S.C. § 101, particularly for software and image processing claims focusing on the requirement for specific "how" details beyond abstract ideas (Longitude Licensing v. Google), induced infringement in the cont...

Geoscope alleged that Google and Apple infringed on several of its patents related to determining the location of mobile devices. The district court had found the patents were directed to patent ineligible subject matter as abstract ideas. The Federal Circuit affirms the district court's decision, concluding that the patent claims, while describing comparing data from known and unknown locations t...

The core issue revolves around the interpretation of certain terms within Fintiv's patents related to a "payment handler" or "payment handler service" in a cloud-based transaction system. The District Court had previously ruled these terms indefinite, finding they recited functions without disclosing sufficient structure as required by patent law, specifically under 35 U.S.C. § 112 ¶ 6. The Federa...

Longitude appealed the dismissal by the Northern District of California of its lawsuit against Google for infringement of four patents related to digital image correction. The district court had found the patents ineligible under 35 U.S.C. § 101, a decision the Federal Circuit affirmed. Applying the two-step Alice framework, the court agreed the claims were directed to the abstract idea of adjusti...

North Star sued Latham Pool Products for allegedly infringing its design patent for a rectangular swimming pool with tanning ledges. The district court granted summary judgment for Latham, finding the pool designs plainly dissimilar. Specifically, the court noted North Star's design used straight, geometric shapes, while Latham's featured rounded, curved elements. The Federal Circuit Court of Appe...

This case concerns Franz A. Wakefield's appeal of the District Court's denial of his motion for relief from a prior judgment of patent invalidity against several technology companies. Wakefield's initial patent infringement suit regarding U.S. Patent No. 7,162,696 was previously decided against him. He subsequently filed a motion under Federal Rule of Civil Procedure 60(b), arguing that claims wit...

Metacel accused Rubicon of inducing infringement of its patent (U.S. Patent 10,610,502) for an oral baclofen solution stored at refrigerated temperatures. The core issue was whether Rubicon's proposed label for its generic version, which primarily instructed room temperature storage but permitted refrigeration, would lead users to infringe Metacel's patent. The court affirmed the district court's...

Recentive sued Fox for infringing four of its patents related to using machine learning to generate network maps and event schedules for television broadcasts and live events. The district court initially dismissed the case, finding Recentive's patents claimed ineligible subject matter under patent law. The Federal Circuit affirmed this dismissal, concluding that the patents merely described the a...

This Federal Circuit opinion addresses an appeal by WSOU Investments LLC (Brazos) against F5, Inc. regarding a patent for network traffic distribution. The dispute centered on the interpretation of the term "master device" within the patent claims. The district court had adopted Brazos's proposed construction during claim construction but later granted summary judgment of noninfringement to F5. Br...

Azurity's U.S. Patent No. 10,959,948 relates to a liquid vancomycin formulation. The appeal follows a district court ruling that Alkem's Abbreviated New Drug Application (ANDA) for a generic version did not infringe Azurity's patent. The central issue revolved around whether Azurity disclaimed the inclusion of propylene glycol during the patent's prosecution. The court affirmed the lower court's d...

This Federal Circuit opinion details a long-standing legal battle between AMS-OSRAM and Renesas regarding misappropriated trade secrets for ambient-light sensor technology used in electronics. The court reviews appeals from both parties concerning monetary awards for trade secret misappropriation and breach of a confidentiality agreement. While the court adjusts the date when the trade secret was...

Express Mobile sued GoDaddy for infringing five of its patents related to website building and display technologies. The district court initially ruled in favor of GoDaddy, granting summary judgment of noninfringement for two patents (the '397 family) based on its claim construction and a jury finding of noninfringement for the other three ('755 family). On appeal, the Federal Circuit reversed the...

Janssen sued Mylan for allegedly inducing patent infringement through its proposed generic drug labels for a treatment of missed doses of Janssen's schizophrenia medication, Invega Trinza. The district court found in favor of Janssen, determining that Mylan would likely induce healthcare providers to infringe Janssen's patent and that Mylan failed to prove the patent was invalid. Mylan appealed th...

This Federal Circuit opinion documents an appeal and cross-appeal in a patent infringement lawsuit between Roland Corporation and inMusic Brands concerning electronic drums and cymbals. Roland initially sued inMusic for infringing eight patents. The district court granted partial summary judgment of non-infringement, and a jury subsequently found the remaining patents infringed. Both parties appea...

In this case, Wash World appealed a district court's decision finding infringement of Belanger's patent for a vehicle spray washer with a lighted spray arm. The appellate court addressed issues of claim construction, ultimately finding that WASH WORLD had forfeited most of its arguments by not properly raising them in the lower court. However, the court agreed with Wash World regarding the damages...

In this case, the appeals court affirms the lower court's findings of patent invalidity due to anticipation by prior art and the dismissal of the Lanham Act claim for lack of unambiguous falsity in advertising. It also upholds sanctions against the plaintiffs for bad faith litigation conduct related to disclosing patent ownership changes. However, the court vacates and remands a portion of the san...

Maquet appealed a district court judgment of non-infringement concerning claims in its U.S. Patent No. 10,238,783 related to intravascular blood pump systems. The appellate court reviewed the district court's claim construction of terms like "guide mechanism comprising a lumen" and "guide wire," finding errors in the application of prosecution disclaimer. As a result, the Federal Circuit vacated t...

This case is an appeal by Regeneron Pharmaceuticals against a district court's denial of a preliminary injunction. Regeneron sought to prevent Amgen from marketing a biosimilar of its drug EYLEA®, arguing patent infringement. The central issue is whether Regeneron's patent requires the "VEGF antagonist" and a "buffer" in its formulation to be separate components. The Federal Circuit Court of Appea...

This concerns Innova's appeal of a district court's preliminary injunction favoring Power Probe in a patent infringement lawsuit. Power Probe sued Innova for allegedly infringing its patent on an electrical test device. The district court initially denied the injunction but was reversed on appeal regarding claim construction. Subsequently, the district court granted a preliminary injunction, findi...

The central issue here is the proper calculation of patent term extensions (PTEs) for reissued patents under the Hatch-Waxman Act, specifically whether the extension should be based on the original patent's issue date or the reissued patent's issue date. The court affirms the district court's finding that for reissued patents retaining claims to a drug product that underwent regulatory review afte...

IQRIS Technologies LLC and Point Blank Enterprises, Inc., concerns quick-release systems for tactical vests. IQRIS appealed a district court's summary judgment of noninfringement, which was based on a narrow interpretation of the patent claim term "pull cord." The Federal Circuit reviewed the district court's claim construction, specifically addressing whether a "pull cord" must be directly pulled...

The court affirmed the district court's decision that IMMUNOGEN's patent application for a specific dosing regimen of its cancer drug, IMGN853, was unpatentable due to obviousness. The central issue was whether using an adjusted ideal body weight (AIBW) based dosage of 6 mg/kg for the drug would have been obvious to someone skilled in the art at the time of the invention, considering existing know...

In Odyssey Logistics & Technology Corp. v. Stewart, the court affirmed the dismissal of Odyssey's complaint, which sought to compel the Director of the U.S. Patent and Trademark Office to review a prior Patent Trial and Appeal Board decision. Odyssey's request for review was based on an Appointments Clause challenge, which they raised after the Supreme Court's decision in Arthrex. The court fo...

This Federal Circuit opinion details Celltrion's appeal of a preliminary injunction preventing them from launching a biosimilar version of Regeneron's EYLEA. The court affirms the district court's decision, finding that Celltrion did not demonstrate a substantial question of invalidity regarding Regeneron's patent. Key to the ruling was the patentable distinction found in the '865 patent's stabili...